Your browser doesn't support javascript.
loading
Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions.
Bell, Alan D; MacCallum, Caroline; Margolese, Shari; Walsh, Zach; Wright, Patrick; Daeninck, Paul J; Mandarino, Enrico; Lacasse, Gary; Kaur Deol, Jagpaul; de Freitas, Lauren; St Pierre, Michelle; Belle-Isle, Lynne; Gagnon, Marilou; Bevan, Sian; Sanchez, Tatiana; Arlt, Stephanie; Monahan-Ellison, Max; O'Hara, James; Boivin, Michael; Costiniuk, Cecilia.
Affiliation
  • Bell AD; Department of Family and Community Medicine, University of Toronto, Toronto, Canada.
  • MacCallum C; Faculty of Medicine, Department of Internal Medicine, University of British Columbia, Vancouver, Canada.
  • Margolese S; Canadian HIV Trials Network, University of British Columbia, Vancouver, Canada.
  • Walsh Z; Department of Psychology, University of British Columbia, Kelowna, Canada.
  • Wright P; Canadian AIDS Society, Ottawa, Canada.
  • Daeninck PJ; Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
  • Mandarino E; CancerCare Manitoba, Winnipeg, Canada.
  • Lacasse G; Canadian HIV Trials Network, University of British Columbia, Vancouver, Canada.
  • Kaur Deol J; MJardin Group Canada, Toronto, Canada.
  • de Freitas L; Canadian AIDS Society, Ottawa, Canada.
  • St Pierre M; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
  • Belle-Isle L; Centre for Addiction and Mental Health, Institute for Mental Health Policy Research, Toronto, Canada.
  • Gagnon M; Department of Psychology, University of British Columbia, Kelowna, Canada.
  • Bevan S; Canadian AIDS Society, Ottawa, Canada.
  • Sanchez T; Canadian Institute for Substance Use Research, University of Victoria, Victoria, Canada.
  • Arlt S; Arthritis Society, Toronto, Canada.
  • Monahan-Ellison M; Department of Psychology, University of British Columbia, Kelowna, Canada.
  • O'Hara J; Centre for Addiction and Mental Health, Institute for Mental Health Policy Research, Toronto, Canada.
  • Boivin M; Medical Cannabis Canada, Toronto, Canada.
  • Costiniuk C; Independent Consultant, Toronto, Canada.
Cannabis Cannabinoid Res ; 9(2): 669-687, 2024 Apr.
Article in En | MEDLINE | ID: mdl-36971587
ABSTRACT

Background:

One in five individuals live with chronic pain globally, which often co-occurs with sleep problems, anxiety, depression, and substance use disorders. Although these conditions are commonly managed with cannabinoid-based medicines (CBM), health care providers report lack of information on the risks, benefits, and appropriate use of CBM for therapeutic purposes.

Aims:

We present these clinical practice guidelines to help clinicians and patients navigate appropriate CBM use in the management of chronic pain and co-occurring conditions. Materials and

Methods:

We conducted a systematic review of studies investigating the use of CBM for the treatment of chronic pain. Articles were dually reviewed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Clinical recommendations were developed based on available evidence from the review. Values and preferences and practical tips have also been provided to support clinical application. The GRADE system was used to rate the strength of recommendations and quality of evidence.

Results:

From our literature search, 70 articles met inclusion criteria and were utilized in guideline development, including 19 systematic reviews and 51 original research studies. Research typically demonstrates moderate benefit of CBM in chronic pain management. There is also evidence for efficacy of CBM in the management of comorbidities, including sleep problems, anxiety, appetite suppression, and for managing symptoms in some chronic conditions associated with pain including HIV, multiple sclerosis, fibromyalgia, and arthritis.

Conclusions:

All patients considering CBM should be educated on risks and adverse events. Patients and clinicians should work collaboratively to identify appropriate dosing, titration, and administration routes for each individual. Systematic Review Registration PROSPERO no. 135886.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sleep Wake Disorders / Cannabinoids / Cannabis / Chronic Pain / Hallucinogens Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Cannabis Cannabinoid Res Year: 2024 Document type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sleep Wake Disorders / Cannabinoids / Cannabis / Chronic Pain / Hallucinogens Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Cannabis Cannabinoid Res Year: 2024 Document type: Article Affiliation country: Canada
...